Low-dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.

Rouchelle S Sriranjan Tian Xiao ZhaoJason TarkinAnnette HubschJoanna HelmyEvangelia VamvakaNavazh JalaludeenSimon BondStephen P HoolePhilip KnottSamantha BuckenhamVictoria WarnesNick BirdHeok CheowHeike TemplinPaul CacciottoloJames H F RuddZiad MallatJoseph Cheriyan

Published in: BMJ open (2022)

NCT04241601.

Keyphrases

phase ii
placebo controlled
clinical trial
double blind
open label
low dose
phase iii
study protocol
phase ii study
liver failure
randomized controlled trial
high dose
respiratory failure
radiation therapy
aortic dissection
mechanical ventilation
locally advanced